comparison between two corticosteroid nasal spray on allergic rhinitis symptoms

comparison between Floticasone and Mometasone nasal sprays on allergic rhinitis symptoms

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016031419240N2

Enrollment

Registered

2016-04-28

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Allergic rhinitis, unspecified

Interventions

Intervention 1: Fluticasone nasal spray 200 micro grams/day (2 puff in each nostril) for 8 weeks. Intervention 2: Mometasone nasal spray 100 micro grams/day (2 puff in each nostril) for 8 weeks.

Treatment - Drugs

Fluticasone nasal spray 200 micro grams/day (2 puff in each nostril) for 8 weeks

Mometasone nasal spray 100 micro grams/day (2 puff in each nostril) for 8 weeks

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) having allergic rhinitis based on clinical exams and questionnaire; 2) having dermatitis allergy to allergen. Exclusion criteria: 1) having infection in two previous weeks; 2) having upper/ lower respiratory infection in two previous weeks; 3) using inhaled steroids in two previous weeks; 4) having nasal polyp.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nasal congestion. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Nasal itching. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Postnasal drip. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Runny nose. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Smelling disorders. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Sneezing. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.	—

Measure

Time frame

Nasal congestion. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Nasal itching. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Postnasal drip. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Runny nose. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Smelling disorders. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.;Sneezing. Timepoint: 0 & 4 & 8 weeks. Method of measurement: TNSS score.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahshid sadat Mirmoezi

Sabzevar University of medical sciences

mahshid.mirmoezi@yahoo.com+98 51 5725 2216

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026